Journal of cardiovascular disease research Impact Factor & Information

Publisher: Medknow Publications

Journal description

Current impact factor: 0.00

Impact Factor Rankings

Additional details

5-year impact 0.00
Cited half-life 0.00
Immediacy index 0.00
Eigenfactor 0.00
Article influence 0.00
ISSN 0976-2833

Publisher details

Medknow Publications

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Non-commercial
    • Publisher's version/PDF may be used
    • Creative Commons Attribution Non-Commercial Share Alike License
    • Published source must be acknowledged
    • All titles are open access journals
  • Classification
    ​ green

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: Pulmonary artery aneurysm is rare condition in neonates which usually presents with compression on the surrounding vital structures. By definition, an aneurysm is focal dilatation of a blood vessel that involves all three layers of vessel wall. Pulmonary artery aneurysm is defined as focal or fusiform dilatation of the PA beyond its maximum normal caliber. Early recognition and treatment are important for reducing morbidity and preventing mortality. The patients of PAA can be absolutely asymptomatic clinically and may be detected on radiograph or computed tomography or echocardiography. They may present as chest pain, dysnoea, or hemoptysis. It requires multidisciplinary approach for the diagnosis and treatment. It is very important to diagnose and manage the PAA as early as possible due to its high morbidity and mortality. Hence CTA is most important for the accurate evaluation of the PAA for its prompt diagnosis and treatment to reduce the risk of morbidity and mortality. Management of the PAA is surgical as well as medical depending upon the risk factors. The conservative management of PAA is serial follow up and periodic assessment of PAA. This is first case report of congenital aneurysm of pulmonary artery causing extrinsic compression over the left main bronchus leading to collapse. The case was successfully managed with surgical translocation of RPA in front of Ascending aorta, angioplasty of MPA & LPA and repair of the ASD; thereby relieving the compression over the left main bronchus and future complications.
    Journal of cardiovascular disease research 03/2015; 6(1):31-36. DOI:10.5530/jcdr.2015.1.6
  • Source
    Journal of cardiovascular disease research 11/2014; 5(3). DOI:10.5530/jcdr.2014.3.7
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Coronary artery disease (CAD) remains a major global public health problem in 21st century, and it affects as many as 54 million people globally.1 The goals of CAD treatment have several objectives which include relief of symptoms, inhibition of disease progression, prevention of future cardiac events, such as myocardial infarction (MI) and improved survival.2 There is always debate among medical treatment and revascularization which one is superior to each other. Here, we will discuss and try to review in a critical manner the role of revascularization (percutaneous coronary intervention [PCI] versus coronary artery bypass grafting [CABG]) in the management of chronic stable angina in comparison to modern optimal medical therapy (OMT) in the view of recent studies.
    Journal of cardiovascular disease research 11/2014; 5(3). DOI:10.5530/jcdr.2014.3.3
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to compare the performance of nurses and medical staff in using two methods of hemodynamic monitoring in cardiac surgery patients. We designed a double-blind study in which nurses and physicians measured cardiac output and other hemodynamic variables using pulmonary artery catheter thermodilution (PACTD; the ‘gold standard’) and a comparator (continuous cardiac dynamic monitoring [CCDM]-HeartSmart®). Hemodynamic values measured using PACTD and HeartSmart® were comparable between nurses and physicians. In addition, PACTD measurements were in good agreement with those derived from CCDM-HeartSmart®. Specialized Cardiac Intensive Care Unit (CICU) nurses are as competent as any member of the medical staff in measuring hemodynamic measurements using PACTD
    Journal of cardiovascular disease research 04/2014; 2(2).
  • [Show abstract] [Hide abstract]
    ABSTRACT: Case Study
    Journal of cardiovascular disease research 03/2014; 2329(2):2.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Many types of cardiac arrhythmias have been noted following acute myocardial infarction. Polymorphic ventricular arrhythmias (polymorphic ventricular tachycardia and ventricular fibrillation) related to an acute myocardial infarction generally strike during the hyperacute phase, are clearly related to ischaemia and are not associated with a long QT interval time. Pause-dependent Torsade de pointes has been reported following acute myocardial infarction and this arrhythmia generally occurs 3–11 days after the onset of acute myocardial infarction and none has been reported during the hyperacute phase. Torsade de pointes – a specific ventricular tachycardia with specific characteristics has been described in hypokalemia, hypomagnesaemia, during Quinidine therapy, and while using phenothiazines and tricyclic antidepressants. It is reported following liquid protein diet, brady-arrhythmias [especially III° AV Block], sick-sinus syndromes. Torsade de pointes either pause-dependent or pause-independent occurring directly as a reperfusion arrhythmia during intravenous thrombolytic therapy has not been reported in the literature to the best of the authors knowledge. Here, an episode of Torsade de pointes as a direct consequence of reperfusion following thrombolytic therapy in a patient of acute myocardial infarction is described.
    Journal of cardiovascular disease research 03/2014; 4(4). DOI:10.1016/j.jcdr.2014.01.007
  • [Show abstract] [Hide abstract]
    ABSTRACT: a b s t r a c t Background: A wide variation exists in the patterns of pharmacotherapy among patients admitted with cardiovascular diseases. Very few studies have evaluated the potential determinants of drug utilization. Our objective was to evaluate the clinical characteristics and patterns of cardiovascular drug utilization among patients in coronary care unit (CCU) and assess the determinants of cardiovascular drug use among patients with coronary artery disease (CAD). Methods: In this retrospective cohort study, the medical records of CCU patients were reviewed independently by two trained physicians over one year. Patients were analyzed as two groups e those with CAD and without CAD. Multivariate logistic regression was done to identify the determinants of cardiovascular drug utilization in the CAD group. Results: Of 574 patients, 65% were males, 57% were <60 years. The five commonly prescribed drug classes were platelet inhibitors (88.7%), statins (76.3%), ACE-inhibitors/Angiotensin receptor blockers (72%), beta-blockers (58%) and heparin (57%). Poly-pharmacy (>5 drugs) was noticed in 71% of patients. A majority of patients had diagnosis of CAD (72.6%). CAD patients received significantly higher median number of drugs and had longer duration of CCU stay (p < 0.0001). Renal dysfunction for ACE-inhibitors [0.18 (0.09e0.36)], ST-elevation myocardial infarction for calcium channel blockers [0.29 (0.09e0.93)] and brady-arrhythmias for beta-blockers [0.3 (0.2e0.7)] were identified as determinants of decreased drug use in CAD group. Conclusion: Predominance of male gender, age <60 and poly-pharmacy was observed in CCU. Antithrombotics, statins, ACE-inhibitors/Angiotensin receptor blockers and beta-blockers were the most frequently prescribed drugs. Clinical co-morbidities (renal dysfunction, arrhythmias) decreased the utilization of ACE-inhibitors, beta-blockers among CAD patients. Copyright � 2013, SciBioIMed.Org, Published by Reed Elsevier India Pvt. Ltd. All rights reserved.
    Journal of cardiovascular disease research 02/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Acute myocardial infarction (AMI) concomitant with aortic dissection (AD) is rare but a devastating situation if misdiagnosed as simply AMI, followed by anticoagulant or thrombolytic therapy. In such cases, Standford type B AD was extremely infrequent. Objectives To present a case with apparent concordance with the patient's history, symptoms, cardiac enzymes that lead to diagnostic error. Case report An 85-year-old man with chronic hypertension and coronary atherosclerotic heart disease presented in our emergency department with squeezing retrosternal chest pain and dyspnea. Elevated cardiac enzymes and electrocardiography result suggested acute non-ST-segment elevation myocardial infarction. Emergency coronary angiography demonstrated a 50–90% diffuse stenosis of the proximal and mid right coronary artery also confirmed the diagnosis. Stents were deployed thereafter. However, the patient was found to be concomitant with Standford type B AD by computed tomography angiography due to unrelieved chest pain and new onset of abdominal pain after the operation. The patient refused to have endovascular operation and died of hemorrhagic shock one week later. Conclusions AD may cause AMI due to some indirect mechanisms, and it is of utmost importance to search for the existence of AD before reperfusion therapy in AMI patients. Aortic dissection detection risk score, transthoracic echocardiography and D-dimer help early identification of AD.
    Journal of cardiovascular disease research 02/2014; 4(4). DOI:10.1016/j.jcdr.2013.12.002